AP
HZNP

AHL Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

AHL Partners’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-106,405
Closed -$1.35M – 1425
2017
Q3 		$1.35M Buy
106,405
+70,393
+195% +$895K 0.02% 789
2017
Q2 		$427K Buy
36,012
+18,183
+102% +$226K 0.01% 960
2017
Q1 		$263K Sell
17,829
-41,944
-70% -$679K 0.01% 1104
2016
Q4 		$967K Buy
+59,773
New +$1.08M 0.03% 670
2016
Q1 		– Sell
-46,321
Closed -$1M – 867
2015
Q4 		$1M Buy
+46,321
New +$902K 0.08% 362

Other funds holding HZNP

SCM
Scopia Capital Management New York $144M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return